[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Notices]
[Pages 21256-21257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08017]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee on the Validation of
Alternative Methods; Notice of Public Webcast; Request for Public Input
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) will hold a public forum to share
information and facilitate direct communication of ideas and
suggestions from stakeholders. Interested persons may view the
presentations by webcast. Time will be set aside for questions and
public statements on the topics discussed. Registration is required for
both webcast viewing and oral statements. Information about the meeting
and registration are available at https://ntp.niehs.nih.gov/go/iccvamforum-2020.
DATES:
Webcast: May 21, 2020, 9:00 a.m. to approximately 3:00 p.m. EDT.
Registration for Webcast: April 17, 2020, until 3:00 p.m. EDT May
21, 2020.
Registration for Oral Statements: April 17, 2020, until 4:00 p.m.
EDT May 8, 2020.
Registration to view the webcast and present oral public statements
is required.
ADDRESSES:
Meeting web page: A preliminary agenda will be posted by May 1 at
https://ntp.niehs.nih.gov/go/iccvamforum-2020.
Webcast: The meeting will be webcast; information to connect to the
webcast will be provided to those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr. Nicole Kleinstreuer, Acting
Director, National Toxicology Program Interagency Center for the
Evaluation of Alternative Toxicological Methods (NICEATM), Division of
NTP, NIEHS, P.O. Box 12233, K2-17, Research Triangle Park, NC 27709.
Phone: 984-287-3150, Email: [email protected]. Hand Deliver/
Courier address: 530 Davis Drive, Room K2021, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM, a congressionally mandated committee, promotes
the development and validation of alternative testing strategies that
protect human health and the environment while replacing, reducing, or
refining animal use.
ICCVAM's goals include promotion of national and international
partnerships between governmental and nongovernmental groups, including
academia, industry, advocacy groups, and other key stakeholders. To
foster
[[Page 21257]]
these partnerships ICCVAM initiated annual public forums in 2014 to
share information and facilitate direct communication of ideas and
suggestions from stakeholders (79 FR 25136).
This year's meeting will be held on May 21, 2020. Due to
restrictions on in-person gatherings amid ongoing public health
concerns, the public forum will be presented via webcast only. NICEATM
and ICCVAM members will give presentations on current activities
related to the development and validation of alternative test methods
and approaches, including activities relevant to implementation of the
strategic roadmap for establishing new approaches to evaluate the
safety of chemicals and medical products in the United States (83 FR
7487).
There will be opportunities for registered participants to ask
clarifying or follow-up questions of the ICCVAM members about their
presentations. Instructions for submitting these questions will be
provided via email prior to the webcast. The agenda will also include
time for public oral statements relevant to the ICCVAM mission and
current activities from participants who have registered to do so in
advance.
Preliminary Agenda and Other Meeting Information: A preliminary
agenda will be posted by May 1 at https://ntp.niehs.nih.gov/go/iccvamforum-2020. Interested individuals are encouraged to visit this
web page to stay abreast of the most current meeting information.
Webcast and Registration: This webcast is open to the public.
Registration for the webcast is required and is open through 3:00 p.m.
EDT on May 21, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020.
Registrants will receive instructions on how to access and participate
in the webcast in the email confirming their registration.
Individuals with disabilities who need accommodation to participate
in this event should contact Elizabeth Maull at phone: (984) 287-3157
or email: [email protected]. TTY users should contact the Federal TTY
Relay Service at (800) 877-8339. Requests should be made at least five
business days in advance of the event.
Request for Oral Public Statements: In addition to time for
clarifying or follow-up questions following scheduled presentations,
time will be allotted during the meeting for oral public statements
with associated slides on topics relevant to ICCVAM's mission. Separate
registration for those wishing to provide public statements is required
and is open through May 8, 2020 at https://ntp.niehs.nih.gov/go/commprac-2020. Any participant registered for the webcast may ask
clarifying questions during the appropriate times in the agenda. The
additional registration is only required for those who wish to give
separate public statements. The number and length of presentations may
be limited based on available time. Submitters will be identified by
their name and affiliation and/or sponsoring organization, if
applicable. Persons submitting public statements and/or associated
slides should include their name, affiliation (if any), mailing
address, telephone, email, and sponsoring organization (if any) with
the document. National Toxicology Program guidelines for public
statements are at http://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
Participants registered to present oral public statements must
email their statement to [email protected] by May 8, 2020,
to allow time for review by NICEATM and ICCVAM and posting to the
meeting page prior to the forum. Persons presenting oral public
statements will be contacted to arrange the logistics of their
presentations. Written statements may supplement and expand the oral
presentation. Public statements will be distributed to NICEATM and
ICCVAM members before the meeting.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM and NICEATM: ICCVAM is an
interagency committee composed of representatives from 16 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability and promotes the scientific validation and regulatory
acceptance of testing methods that more accurately assess the safety
and hazards of chemicals and products and replace, reduce, or refine
(enhance animal well-being and lessen or avoid pain and distress)
animal use.
The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes
ICCVAM as a permanent interagency committee of NIEHS and provides the
authority for ICCVAM involvement in activities relevant to the
development of alternative test methods. Additional information about
ICCVAM can be found at https://ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative test methods and strategies for
validation studies and technical evaluations. Additional information
about NICEATM can be found at https://ntp.niehs.nih.gov/go/niceatm.
Dated: April 7, 2020.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2020-08017 Filed 4-15-20; 8:45 am]
BILLING CODE 4140-01-P